MAPK3 and gastric cancer: Our initial results indicated that the EMT of GC cells induced by IL-33 was inhibited by U0126 (Fig. 2o–r), we therefore assessed whether CAFs-derived IL-33 could modulate the activation of the ERK1/2 pathway in GC cells.